How CAR T-cell therapies target myeloma at the molecular level

In multiple myeloma, plasma cells proliferate uncontrollably in the bone marrow, disrupting the growth of healthy blood-forming cells. If the disease recurs after treatment or fails to respond, CAR T-cell therapy may be considered. In this…

Continue Reading

News Source: medicalxpress.com